JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by POLLARD, A. A.
Right arrow Articles by BECK, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by POLLARD, A. A.
Right arrow Articles by BECK, L.
Journal of Pharmacology And Experimental Therapeutics, Vol. 179, Issue 1, 132-143, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics


THE DISTINCT NATURE OF THE SUSTAINED DILATOR SYSTEM: EVIDENCE AGAINST THE PSEUDOTRANSMITTER HYPOTHESIS

A. A. POLLARD 1 and L. BECK 1

1 Departments of Pharmacology, The University of New Mexico School of Medicine, Albuquerque, New Mexico; The University of Michigan School of Medicine, Ann Arbor, Michigan

A sustained vasodilatation occurs in the perfused dog hindlimb during lumbar sympathetic chain stimulation after inactivation or depletion of adrenergic neurons. The existence of the vasodilator system is more easily demonstrated after administration of drugs which deplete or prevent release of adrenergic amines, suggesting that the sustained dilator system is largely masked, or prevented from being activated, by the functionally discharging adrenergic system. The purpose of the present investigation was to explore the possibility that sustained dilatation occurs as a result of change in the function of adrenergic neurons from vasoconstriction to vasodilatation. It is concluded that sustained dilatation does not result from neurosecretion of adrenergic antirelease or depleting agents because stimulation of the lumbar sympathetic nerves in dogs pretreated with reserpine results in large sustained dilatations even though reserpine, itself, fails to elicit a vascular dilatation in pretreated dogs. Xylocholine and guanethidine are capable of producing large vascular dilatations in the dog depleted of adrenergic amines, but the dose required to produce dilatation exceeds by more than 10.000 times the theoretical amount which would be released from nerve endings if these agents functioned as false transmitters. Intermediates of adrenergic amine synthesis and adrenergic metabolites have also been ruled out as potential false transmitters of adrenergic neurons. Evidence has also been obtained that the sustained dilator system can be activated in the absence of drug treatment. This latent sympathetic vasodilator system is therefore deemed to be physiologically and anatomically separate from the adrenergic system.

Submitted on January 21, 1971
Accepted on June 1, 1971







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.